The annual accounts for medicine wholesaler Europharma show revenue of NOK 394.5 million (€48.2 million/$61.2 million) in 2013 down 1.4 percent compared with NOK 400.1 million (€48.9 million/$62.1 million) the previous year.
Operating profit also dropped to NOK 18.4 million (€2.2 million/$2.9 million) from NOK 22.3 million (€2.7 million/$3.5 million) in the same period.
Most of the revenue came from sales in Norway. Around NOK 2 million (€244,556/$310,500) was from sales in Europe, Canada and Chile.
“Company turnover is still developing positively in the segments where the company operates,” the Board of Directors wrote in this year’s report.
Pre-tax
